LUNG Q1 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+34.8% YoY

Gross Profit

$11M72.9% margin

Operating Income

-$16M-112.8% margin

Net Income

-$16M-109.1% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

-5.8%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$201M

Total Liabilities

$57M

Stockholders' Equity

$144M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$11M	+34.8%
Gross Profit	$11M	$8M	+30.6%
Operating Income	-$16M	-$16M	-4.7%
Net Income	-$16M	-$16M	-0.2%

Geographic Segments

UNITED STATES

$9M64%

EMEA

$5M31%

Asia Pacific

$596,0004%

Other International Geographical Areas

$71,0000%